Alkermes-Biogen’s MS drug shows improved GI tolerability

Diroximel fumarate is an investigational, oral fumarate candidate intended for treating relapsing forms of multiple sclerosis. Credit: Birth Into Being.



  • Alkermes-Biogen’s MS drug diroximel fumarate shows better GI tolerability